Autologous hematopoietic stem cell transplantation for relapsed follicular lymphoma: safety profile and clinical outcome in a single-center experience

Autologous hematopoietic stem cell transplantation (AHSCT) is a treatment option for relapsed and recurrent follicular lymphoma (R/R FL); however, its value in the rituximab era remains to be elucidated. To evaluate the safety and clinical outcome of AHSCT for relapsed FL, we present a retrospective...

Descripción completa

Detalles Bibliográficos
Autores principales: Helbig, Grzegorz, Krawczyk-Kulis, Malgorzata, Kopinska, Anna, Liwoch, Robert, Kyrcz-Krzemien, Slawomira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2014
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4221626/
https://www.ncbi.nlm.nih.gov/pubmed/25373321
http://dx.doi.org/10.1007/s12032-014-0310-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4221626/
https://www.ncbi.nlm.nih.gov/pubmed/25373321
http://dx.doi.org/10.1007/s12032-014-0310-3

Ejemplares similares